1-4 of 4
Jason Lickliter
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Transmembrane Protease, Serine 6 (TMPRSS6) Antisense Oligonucleotide (IONIS-TMPRSS6-L RX ) Reduces Plasma Iron Levels of Healthy Volunteers in a Phase 1 Clinical Study

Michael McCaleb, PhD, Jason Lickliter, MBBS, PhD, Andrew Dibble, PhD, Eugene Schneider, MD, Mariam Aghajan, Shuling Guo, Steve Hughes, MD MBA, Richard S Geary, PhD, Brett P. Monia, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3634.
https://doi.org/10.1182/blood-2018-99-115339
Published: 2018
Journal Articles

APL-2, a Complement C3 Inhibitor for the Potential Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH): Phase I Data from Two Completed Studies in Healthy Volunteers

Federico V Grossi, MDPhD, Pauline Bedwell, Pascal Deschatelets, PhD, Lil Edis, PhD, Cedric G Francois, MDPhD, Patrick J Johnson, PhD, Helen J Richardson, Lisa Tan, Carolina A Vega, Jason Lickliter, MBBS,PhD
Journal: Blood
Blood (2016) 128 (22): 1251.
https://doi.org/10.1182/blood.V128.22.1251.1251
Published: 2016
Journal Articles

Phase II Pilot Study of Imatinib Mesylate Combined with Induction Chemotherapy in Blast-Phase CML and Ph+ ALL.

Jason Lickliter, MD, Chris Arthur, MD, James D’Rozario, MD, Chi-hung Hui, MD, Jeffrey Szer, MD, Kerry Taylor, MD, Anne-Marie Watson, MD, Jennifer McCarron, BSc, Kevin Lynch, MD, Ken Bradstock, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 4682.
https://doi.org/10.1182/blood.V104.11.4682.4682
Published: 2004
Journal Articles

A Small-Molecule Bcl-2 Inhibitor Amplifies NKT-Cell Killing of U937 Lymphoma Cells.

Jason Lickliter, Joanne Cox, Mie Nieda, Henry Lin, Andrew Nicol
Journal: Blood
Blood (2004) 104 (11): 1399.
https://doi.org/10.1182/blood.V104.11.1399.1399
Published: 2004